Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1219626

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1219626

Global Bioprocess Validation Market Size, Share & Industry Trends Analysis Report By Stage, By Mode, By Testing Type, By Regional Outlook and Forecast, 2022 - 2028

PUBLISHED:
PAGES: 221 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Site License)
USD 4320
PDF (Enterprisewide License)
USD 6048

Add to Cart

The Global Bioprocess Validation Market size is expected to reach $650.6 Million by 2028, rising at a market growth of 8.5% CAGR during the forecast period.

The documentation of all procedures, evidence, and activities of the process of biological and biopharmaceutical product formation is known as bioprocess validation. The documentation is performed as per the guidelines of various regulatory bodies, for instance, US FDA (Food and Drug Administration).

It ensures the maintenance of compliance in all the stages of the product testing procedures. Assessing Active Pharmaceutical Ingredients (API) and impurities is essential to bioprocess validation. The primary principle of validation is to ensure that every process of the bioproduct processing is evaluated, which provides quality products, maintaining scientifically documented evidence.

Quality, efficacy, and safety are maintained during the bioprocess validation. Validation has become an essential issue in manufacturing biopharmaceuticals or biologies intended for therapeutic usage. In addition to the validation of final product quality, manufacturing process validation is gaining wide attention. Bioprocesses are sensitive and delicate and hence require careful planning and organization for successful process validation. As a result, bioprocess chromatography is the most generally utilized unit operation in biologics manufacturing.

COVID-19 Impact Analysis

The COVID-19 pandemic has adversely impacted the world economy due to the imposed lockdown, business shutdown, and restriction on travel. This critically affected numerous industries' manufacturing plants and factories, affecting the sales and product supply chains negatively. The rising COVID-19 infections have led to the development of precision medicines and biosimilars that raise the demands for outsourcing services and the bioprocess validation process. As a result, major market players have also started to enhance and implement the validation process for the bioprocess of biologics and drug developments. An effective validation ensures the product's safety, quality, and efficiency, which is expected further to surge the market growth of the bioprocess validation.

Market Growth Factors

The rise in the need to outsource bioprocess validation

In the pharmaceutical sector, compliance with the standards of different regulatory bodies is essential, which is why bioprocess validation is an integrated process in pharmaceuticals. Validation verifies that all procedures stick to the stated requirements by the government's regulations. Any validation method requires exhaustive documentation that conforms to standard operating procedures and ongoing activities. Pharmaceutical manufacturing is being outsourced to third-party service providers to raise production yields. The wide usage of disposable technologies in medication development aids in reducing production costs. The increasing outsourcing of bioprocesses validation to third-party service providers will propel the growth of the bioprocess validation market.

Rising usage of single use bioprocessing

The implementation of single-use bioprocessing systems enhances manufacturing processes' productivity by reducing automation's cost and complexity. It also eliminates the requirement for changeover cleaning/validation between consecutive operations. In addition, single-use bioprocessing systems eliminate the need for additional investments by removing the requirement for sterilization. The initial investment costs with single-use bioprocessing systems are lower compared to that of the stainless-steel facility at the same scale, making it suitable for new players with low investments. Thereby boosting the demand for the bioprocess validation market.

Market Restraining Factors

Possible issues with extractables & leachable

The food and pharmaceutical sectors are dealing with difficulties with the trace quantity of contaminants generated by the extraction or leaching process. Even after the strict regulations of many nations' governments, corporations are still disregarding such issues and the risk to the lives of consumers/patients. Pharmaceutical manufacturers and regulatory agencies are concerned with extractable and leachable. Any containers and pharmaceutical packaging system, including plastic bottles, labeling ink, packing materials, glass, and foil pouches, can leach undesired pollutants into the food ingredient or drug products. Oral drugs, parental and ophthalmic products often pose a more eminent danger. Hence, the issues related to extractables and leachable are expected to hamper the growth of the bioprocess validation market.

Testing Type Outlook

Based on testing type, the bioprocess validation market is segmented into extractables & leachables testing, bioprocess residuals testing, viral clearance testing, filtration & fermentation systems testing and others. The extractables & leachables testing segment garnered a significant revenue share in the bioprocess validation market in 2021. The growth is attributed to the presence of good manufacturing practice guidelines and US FDA regulations. Due to this, there is a huge demand for certified quality bioproducts. The biotechnology and biopharmaceutical companies are engaged in manufacturing cGMP-certified bioproducts. The requirement for government-certified products will propel the segment's growth in the forecasted period.

Stage Outlook

On the basis of stage, the bioprocess validation market is divided into process design, process qualification, and continued process verification. The continued process verification segment witnessed the largest revenue share in the bioprocess validation market in 2021. This is because it collects the processing, data collection analysis, and storage of every batch. The primary reasons for creating a continued process verification plan are to achieve compliance with regulatory bodies, prevent batch discards, and mitigate process vulnerabilities while finding constant enhancement possibilities. These features and the automation in this process will boost the segment's expansion.

Mode Outlook

By mode, the bioprocess validation market is bifurcated into in house and outsourced. The outsourced segment projected a substantial revenue share in the bioprocess validation market in 2021. This is due to biopharmaceutical and biotechnology companies' high demand for testing services. There is an increase in expenditure for healthcare and the supply of raw materials needed by the market players. In addition, there is also a rising number of CDMOs (Contract Development and Manufacturing Organization) providing drug development and manufacturing services to the pharma and biopharma industries.

Regional Outlook

Region-wise, the bioprocess validation market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region dominated the bioprocess validation market with the largest revenue share in 2021. This is because of significant outsourcing services providers in the region, which leads to the rise in life science research and the production of biologics. Also, the region has many FDA-approved biopharmaceuticals and biotechnological industries. The increased government funding for the bioprocess validation process and the conduct of clinical trials, combined with the presence of many key players, will surge the market's growth in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Sartorius AG, Merck KGaA, Lonza Group AG, Danaher Corporation, Charles River Laboratories International, Inc., SGS S.A., Labcorp Corporation, and Cobetter Filtration equipment Co., Ltd.

Strategies Deployed in Bioprocess Validation Market

Sep-2022: Lonza collaborated with Touchlight, a biotechnology company. With this collaboration, Lonza would have the capacity to combine a diverse, additional source of DNA in its complete suite for customers developing messenger RNA vaccines and therapeutics and at the same time Touchlight could broaden the channels through which customers can earn access to Lonza's novel doggy bone DNA (dbDNA) technology.

Aug-2022: Thermo Fisher Scientific opened a dry powder media manufacturing facility in Grand Island, New York. The new facility would offer the inessential potential to assist the global supply of media and further broadens the site's abilities to deliver the quality technology and materials required for the commercial manufacturing and development of biological and vaccine therapies.

Jun-2022: Merck collaborated with Agilent Technologies, a leader in life diagnostics, sciences, and applied chemical markets. Under this collaboration, both companies would advance bioprocess offering with Agilent's leading analytical solutions to provide combined abilities for improved downstream process control and monitoring.

Feb-2022-Feb: Sartorius Stedim Biotech, a subgroup of Sartorius, completed the acquisition of the chromatography division of Novasep, a leading supplier of services in the field of purification and molecule production. The acquisition of a chromatography suite consists of chromatography systems suitable for smaller biomolecules and advanced systems for the continuous production of biologics.

May-2021: Eurofins BioPharma Product Testing Columbia signed an agreement with Plus Therapeutics, Inc., a clinical-stage pharmaceutical company. Through this Agreement, Eurofins would develop and validate test methods for the composition, and identity of Re-BMEDA, the active pharmaceutical ingredient (API) in RNL and purity.

Jan-2021: Sartorius collaborated with RoosterBio, Inc., a leading provider of highly engineered media, human mesenchymal stem/stromal cell working cell banks, and hMSC bioprocess systems. Under the collaboration, both companies would aim to advance the development of hMSC manufacturing of regenerative medicine by enhancing the quality solutions of both companies to notably decrease process development efforts, industrialize the supply chain and boost the development and production of better cell-based regenerative cures.

Dec-2020: Sartorius completed the acquisition WaterSep BioSeparations LLC, a U.S.-based purification expert. This acquisition aligns with the company's current suite for cell and gene therapy applications, cell harvesting, and multiple solutions for robust bioprocessing.

Apr-2020: Merck launched BioContinuum™ Platform, the Bio4C™ Software Suite, making a first-of-its-kind ecosystem that integrates process management, plant-level automation, and analytics. The launched product portfolio would enable users to view the complete manufacturing process versus particular operational units, delivering biomanufacturers comprehensive deep insights and process control.

Apr-2020: Sartorius announced the acquisition of selected life science businesses of Danaher Corporation, a globally diversified conglomerate company. This acquisition would help customers completely in the advancement of biotech medicines and vaccines, also in the protected and smooth production of the same pharmaceuticals.

May-2018: Eurofins Scientific acquired PHAST, a leading service provider in the field of pharmaceutical product quality. This acquisition would align with Eurofins' BioPharma Product Testing abilities and broadens its geographical reach in these markets.

Scope of the Study

Market Segments covered in the Report:

By Stage

  • Continued Process Verification
  • Process Qualification
  • Process Design

By Mode

  • In House
  • Outsourced

By Testing Type

  • Bioprocess Residuals Testing
  • Extractables & Leachables Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Sartorius AG
  • Merck KGaA
  • Lonza Group AG
  • Danaher Corporation
  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Labcorp Corporation
  • Cobetter Filtration equipment Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Bioprocess Validation Market, by Stage
    • 1.4.2 Global Bioprocess Validation Market, by Mode
    • 1.4.3 Global Bioprocess Validation Market, by Testing Type
    • 1.4.4 Global Bioprocess Validation Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Bioprocess Validation Market

Chapter 4. Global Bioprocess Validation Market by Stage

  • 4.1 Global Continued Process Verification Market by Region
  • 4.2 Global Process Qualification Market by Region
  • 4.3 Global Process Design Market by Region

Chapter 5. Global Bioprocess Validation Market by Mode

  • 5.1 Global In House Market by Region
  • 5.2 Global Outsourced Market by Region

Chapter 6. Global Bioprocess Validation Market by Testing Type

  • 6.1 Global Bioprocess Residuals Testing Market by Region
  • 6.2 Global Extractables & Leachables Testing Market by Region
  • 6.3 Global Viral Clearance Testing Market by Region
  • 6.4 Global Filtration & Fermentation Systems Testing Market by Region
  • 6.5 Global Others Market by Region

Chapter 7. Global Bioprocess Validation Market by Region

  • 7.1 North America Bioprocess Validation Market
    • 7.1.1 North America Bioprocess Validation Market by Stage
      • 7.1.1.1 North America Continued Process Verification Market by Country
      • 7.1.1.2 North America Process Qualification Market by Country
      • 7.1.1.3 North America Process Design Market by Country
    • 7.1.2 North America Bioprocess Validation Market by Mode
      • 7.1.2.1 North America In House Market by Country
      • 7.1.2.2 North America Outsourced Market by Country
    • 7.1.3 North America Bioprocess Validation Market by Testing Type
      • 7.1.3.1 North America Bioprocess Residuals Testing Market by Country
      • 7.1.3.2 North America Extractables & Leachables Testing Market by Country
      • 7.1.3.3 North America Viral Clearance Testing Market by Country
      • 7.1.3.4 North America Filtration & Fermentation Systems Testing Market by Country
      • 7.1.3.5 North America Others Market by Country
    • 7.1.4 North America Bioprocess Validation Market by Country
      • 7.1.4.1 US Bioprocess Validation Market
        • 7.1.4.1.1 US Bioprocess Validation Market by Stage
        • 7.1.4.1.2 US Bioprocess Validation Market by Mode
        • 7.1.4.1.3 US Bioprocess Validation Market by Testing Type
      • 7.1.4.2 Canada Bioprocess Validation Market
        • 7.1.4.2.1 Canada Bioprocess Validation Market by Stage
        • 7.1.4.2.2 Canada Bioprocess Validation Market by Mode
        • 7.1.4.2.3 Canada Bioprocess Validation Market by Testing Type
      • 7.1.4.3 Mexico Bioprocess Validation Market
        • 7.1.4.3.1 Mexico Bioprocess Validation Market by Stage
        • 7.1.4.3.2 Mexico Bioprocess Validation Market by Mode
        • 7.1.4.3.3 Mexico Bioprocess Validation Market by Testing Type
      • 7.1.4.4 Rest of North America Bioprocess Validation Market
        • 7.1.4.4.1 Rest of North America Bioprocess Validation Market by Stage
        • 7.1.4.4.2 Rest of North America Bioprocess Validation Market by Mode
        • 7.1.4.4.3 Rest of North America Bioprocess Validation Market by Testing Type
  • 7.2 Europe Bioprocess Validation Market
    • 7.2.1 Europe Bioprocess Validation Market by Stage
      • 7.2.1.1 Europe Continued Process Verification Market by Country
      • 7.2.1.2 Europe Process Qualification Market by Country
      • 7.2.1.3 Europe Process Design Market by Country
    • 7.2.2 Europe Bioprocess Validation Market by Mode
      • 7.2.2.1 Europe In House Market by Country
      • 7.2.2.2 Europe Outsourced Market by Country
    • 7.2.3 Europe Bioprocess Validation Market by Testing Type
      • 7.2.3.1 Europe Bioprocess Residuals Testing Market by Country
      • 7.2.3.2 Europe Extractables & Leachables Testing Market by Country
      • 7.2.3.3 Europe Viral Clearance Testing Market by Country
      • 7.2.3.4 Europe Filtration & Fermentation Systems Testing Market by Country
      • 7.2.3.5 Europe Others Market by Country
    • 7.2.4 Europe Bioprocess Validation Market by Country
      • 7.2.4.1 Germany Bioprocess Validation Market
        • 7.2.4.1.1 Germany Bioprocess Validation Market by Stage
        • 7.2.4.1.2 Germany Bioprocess Validation Market by Mode
        • 7.2.4.1.3 Germany Bioprocess Validation Market by Testing Type
      • 7.2.4.2 UK Bioprocess Validation Market
        • 7.2.4.2.1 UK Bioprocess Validation Market by Stage
        • 7.2.4.2.2 UK Bioprocess Validation Market by Mode
        • 7.2.4.2.3 UK Bioprocess Validation Market by Testing Type
      • 7.2.4.3 France Bioprocess Validation Market
        • 7.2.4.3.1 France Bioprocess Validation Market by Stage
        • 7.2.4.3.2 France Bioprocess Validation Market by Mode
        • 7.2.4.3.3 France Bioprocess Validation Market by Testing Type
      • 7.2.4.4 Russia Bioprocess Validation Market
        • 7.2.4.4.1 Russia Bioprocess Validation Market by Stage
        • 7.2.4.4.2 Russia Bioprocess Validation Market by Mode
        • 7.2.4.4.3 Russia Bioprocess Validation Market by Testing Type
      • 7.2.4.5 Spain Bioprocess Validation Market
        • 7.2.4.5.1 Spain Bioprocess Validation Market by Stage
        • 7.2.4.5.2 Spain Bioprocess Validation Market by Mode
        • 7.2.4.5.3 Spain Bioprocess Validation Market by Testing Type
      • 7.2.4.6 Italy Bioprocess Validation Market
        • 7.2.4.6.1 Italy Bioprocess Validation Market by Stage
        • 7.2.4.6.2 Italy Bioprocess Validation Market by Mode
        • 7.2.4.6.3 Italy Bioprocess Validation Market by Testing Type
      • 7.2.4.7 Rest of Europe Bioprocess Validation Market
        • 7.2.4.7.1 Rest of Europe Bioprocess Validation Market by Stage
        • 7.2.4.7.2 Rest of Europe Bioprocess Validation Market by Mode
        • 7.2.4.7.3 Rest of Europe Bioprocess Validation Market by Testing Type
  • 7.3 Asia Pacific Bioprocess Validation Market
    • 7.3.1 Asia Pacific Bioprocess Validation Market by Stage
      • 7.3.1.1 Asia Pacific Continued Process Verification Market by Country
      • 7.3.1.2 Asia Pacific Process Qualification Market by Country
      • 7.3.1.3 Asia Pacific Process Design Market by Country
    • 7.3.2 Asia Pacific Bioprocess Validation Market by Mode
      • 7.3.2.1 Asia Pacific In House Market by Country
      • 7.3.2.2 Asia Pacific Outsourced Market by Country
    • 7.3.3 Asia Pacific Bioprocess Validation Market by Testing Type
      • 7.3.3.1 Asia Pacific Bioprocess Residuals Testing Market by Country
      • 7.3.3.2 Asia Pacific Extractables & Leachables Testing Market by Country
      • 7.3.3.3 Asia Pacific Viral Clearance Testing Market by Country
      • 7.3.3.4 Asia Pacific Filtration & Fermentation Systems Testing Market by Country
      • 7.3.3.5 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Bioprocess Validation Market by Country
      • 7.3.4.1 China Bioprocess Validation Market
        • 7.3.4.1.1 China Bioprocess Validation Market by Stage
        • 7.3.4.1.2 China Bioprocess Validation Market by Mode
        • 7.3.4.1.3 China Bioprocess Validation Market by Testing Type
      • 7.3.4.2 Japan Bioprocess Validation Market
        • 7.3.4.2.1 Japan Bioprocess Validation Market by Stage
        • 7.3.4.2.2 Japan Bioprocess Validation Market by Mode
        • 7.3.4.2.3 Japan Bioprocess Validation Market by Testing Type
      • 7.3.4.3 India Bioprocess Validation Market
        • 7.3.4.3.1 India Bioprocess Validation Market by Stage
        • 7.3.4.3.2 India Bioprocess Validation Market by Mode
        • 7.3.4.3.3 India Bioprocess Validation Market by Testing Type
      • 7.3.4.4 South Korea Bioprocess Validation Market
        • 7.3.4.4.1 South Korea Bioprocess Validation Market by Stage
        • 7.3.4.4.2 South Korea Bioprocess Validation Market by Mode
        • 7.3.4.4.3 South Korea Bioprocess Validation Market by Testing Type
      • 7.3.4.5 Singapore Bioprocess Validation Market
        • 7.3.4.5.1 Singapore Bioprocess Validation Market by Stage
        • 7.3.4.5.2 Singapore Bioprocess Validation Market by Mode
        • 7.3.4.5.3 Singapore Bioprocess Validation Market by Testing Type
      • 7.3.4.6 Malaysia Bioprocess Validation Market
        • 7.3.4.6.1 Malaysia Bioprocess Validation Market by Stage
        • 7.3.4.6.2 Malaysia Bioprocess Validation Market by Mode
        • 7.3.4.6.3 Malaysia Bioprocess Validation Market by Testing Type
      • 7.3.4.7 Rest of Asia Pacific Bioprocess Validation Market
        • 7.3.4.7.1 Rest of Asia Pacific Bioprocess Validation Market by Stage
        • 7.3.4.7.2 Rest of Asia Pacific Bioprocess Validation Market by Mode
        • 7.3.4.7.3 Rest of Asia Pacific Bioprocess Validation Market by Testing Type
  • 7.4 LAMEA Bioprocess Validation Market
    • 7.4.1 LAMEA Bioprocess Validation Market by Stage
      • 7.4.1.1 LAMEA Continued Process Verification Market by Country
      • 7.4.1.2 LAMEA Process Qualification Market by Country
      • 7.4.1.3 LAMEA Process Design Market by Country
    • 7.4.2 LAMEA Bioprocess Validation Market by Mode
      • 7.4.2.1 LAMEA In House Market by Country
      • 7.4.2.2 LAMEA Outsourced Market by Country
    • 7.4.3 LAMEA Bioprocess Validation Market by Testing Type
      • 7.4.3.1 LAMEA Bioprocess Residuals Testing Market by Country
      • 7.4.3.2 LAMEA Extractables & Leachables Testing Market by Country
      • 7.4.3.3 LAMEA Viral Clearance Testing Market by Country
      • 7.4.3.4 LAMEA Filtration & Fermentation Systems Testing Market by Country
      • 7.4.3.5 LAMEA Others Market by Country
    • 7.4.4 LAMEA Bioprocess Validation Market by Country
      • 7.4.4.1 Brazil Bioprocess Validation Market
        • 7.4.4.1.1 Brazil Bioprocess Validation Market by Stage
        • 7.4.4.1.2 Brazil Bioprocess Validation Market by Mode
        • 7.4.4.1.3 Brazil Bioprocess Validation Market by Testing Type
      • 7.4.4.2 Argentina Bioprocess Validation Market
        • 7.4.4.2.1 Argentina Bioprocess Validation Market by Stage
        • 7.4.4.2.2 Argentina Bioprocess Validation Market by Mode
        • 7.4.4.2.3 Argentina Bioprocess Validation Market by Testing Type
      • 7.4.4.3 UAE Bioprocess Validation Market
        • 7.4.4.3.1 UAE Bioprocess Validation Market by Stage
        • 7.4.4.3.2 UAE Bioprocess Validation Market by Mode
        • 7.4.4.3.3 UAE Bioprocess Validation Market by Testing Type
      • 7.4.4.4 Saudi Arabia Bioprocess Validation Market
        • 7.4.4.4.1 Saudi Arabia Bioprocess Validation Market by Stage
        • 7.4.4.4.2 Saudi Arabia Bioprocess Validation Market by Mode
        • 7.4.4.4.3 Saudi Arabia Bioprocess Validation Market by Testing Type
      • 7.4.4.5 South Africa Bioprocess Validation Market
        • 7.4.4.5.1 South Africa Bioprocess Validation Market by Stage
        • 7.4.4.5.2 South Africa Bioprocess Validation Market by Mode
        • 7.4.4.5.3 South Africa Bioprocess Validation Market by Testing Type
      • 7.4.4.6 Nigeria Bioprocess Validation Market
        • 7.4.4.6.1 Nigeria Bioprocess Validation Market by Stage
        • 7.4.4.6.2 Nigeria Bioprocess Validation Market by Mode
        • 7.4.4.6.3 Nigeria Bioprocess Validation Market by Testing Type
      • 7.4.4.7 Rest of LAMEA Bioprocess Validation Market
        • 7.4.4.7.1 Rest of LAMEA Bioprocess Validation Market by Stage
        • 7.4.4.7.2 Rest of LAMEA Bioprocess Validation Market by Mode
        • 7.4.4.7.3 Rest of LAMEA Bioprocess Validation Market by Testing Type

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Geographical Expansions:
    • 8.1.6 SWOT Analysis
  • 8.2 Eurofins Scientific SE
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Partnerships, Collaborations, and Agreements:
      • 8.2.4.2 Acquisition and Mergers:
  • 8.3 Sartorius AG
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Merck KGaA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Product Launches and Product Expansions:
  • 8.5 Lonza Group AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
  • 8.6 Danaher Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Charles River Laboratories International, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
  • 8.8 SGS S.A.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
  • 8.9 Labcorp Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
  • 8.10. Cobetter Filtration equipment Co., Ltd.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 2 Global Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 3 Global Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 4 Global Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 5 Global Continued Process Verification Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Continued Process Verification Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Process Qualification Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Process Qualification Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Process Design Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Process Design Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 12 Global Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 13 Global In House Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global In House Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Outsourced Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Outsourced Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 18 Global Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 19 Global Bioprocess Residuals Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Bioprocess Residuals Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Extractables & Leachables Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Extractables & Leachables Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Viral Clearance Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Viral Clearance Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Filtration & Fermentation Systems Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Filtration & Fermentation Systems Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Bioprocess Validation Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Bioprocess Validation Market by Region, 2022 - 2028, USD Million
  • TABLE 31 North America Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 32 North America Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 33 North America Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 34 North America Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 35 North America Continued Process Verification Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Continued Process Verification Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Process Qualification Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Process Qualification Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Process Design Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Process Design Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 42 North America Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 43 North America In House Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America In House Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 48 North America Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 49 North America Bioprocess Residuals Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Bioprocess Residuals Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Extractables & Leachables Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Extractables & Leachables Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Viral Clearance Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Viral Clearance Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Filtration & Fermentation Systems Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Filtration & Fermentation Systems Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Bioprocess Validation Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Bioprocess Validation Market by Country, 2022 - 2028, USD Million
  • TABLE 61 US Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 62 US Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 63 US Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 64 US Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 65 US Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 66 US Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 67 US Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 68 US Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 69 Canada Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 70 Canada Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 71 Canada Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 72 Canada Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 73 Canada Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 74 Canada Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 75 Canada Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 76 Canada Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 77 Mexico Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 78 Mexico Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 79 Mexico Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 80 Mexico Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 81 Mexico Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 82 Mexico Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 83 Mexico Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 84 Mexico Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 89 Rest of North America Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 90 Rest of North America Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 91 Rest of North America Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 92 Rest of North America Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 93 Europe Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 94 Europe Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 95 Europe Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 96 Europe Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 97 Europe Continued Process Verification Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Continued Process Verification Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Process Qualification Market by Country, 2018 - 2021, USD Million
  • TABLE 100 Europe Process Qualification Market by Country, 2022 - 2028, USD Million
  • TABLE 101 Europe Process Design Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Process Design Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 104 Europe Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 105 Europe In House Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe In House Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 110 Europe Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 111 Europe Bioprocess Residuals Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Bioprocess Residuals Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Extractables & Leachables Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Extractables & Leachables Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Viral Clearance Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Viral Clearance Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Filtration & Fermentation Systems Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Filtration & Fermentation Systems Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Bioprocess Validation Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Bioprocess Validation Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Germany Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 124 Germany Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 125 Germany Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 126 Germany Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 127 Germany Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 128 Germany Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 129 Germany Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 130 Germany Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 131 UK Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 132 UK Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 133 UK Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 134 UK Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 135 UK Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 136 UK Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 137 UK Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 138 UK Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 139 France Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 140 France Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 141 France Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 142 France Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 143 France Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 144 France Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 145 France Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 146 France Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 147 Russia Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 148 Russia Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 149 Russia Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 150 Russia Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 151 Russia Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 152 Russia Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 153 Russia Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 154 Russia Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 155 Spain Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 156 Spain Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 157 Spain Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 158 Spain Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 159 Spain Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 160 Spain Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 161 Spain Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 162 Spain Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 163 Italy Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 164 Italy Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 165 Italy Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 166 Italy Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 167 Italy Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 168 Italy Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 169 Italy Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 170 Italy Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 173 Rest of Europe Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 174 Rest of Europe Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 175 Rest of Europe Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 176 Rest of Europe Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 177 Rest of Europe Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 178 Rest of Europe Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Continued Process Verification Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Continued Process Verification Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Process Qualification Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Process Qualification Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Process Design Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Process Design Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific In House Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific In House Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Bioprocess Residuals Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Bioprocess Residuals Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Extractables & Leachables Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Extractables & Leachables Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Viral Clearance Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Viral Clearance Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Filtration & Fermentation Systems Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Filtration & Fermentation Systems Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Bioprocess Validation Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Bioprocess Validation Market by Country, 2022 - 2028, USD Million
  • TABLE 209 China Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 210 China Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 211 China Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 212 China Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 213 China Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 214 China Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 215 China Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 216 China Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 217 Japan Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 218 Japan Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 219 Japan Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 220 Japan Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 221 Japan Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 222 Japan Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 223 Japan Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 224 Japan Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 225 India Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 226 India Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 227 India Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 228 India Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 229 India Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 230 India Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 231 India Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 232 India Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 233 South Korea Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 234 South Korea Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 235 South Korea Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 236 South Korea Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 237 South Korea Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 238 South Korea Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 239 South Korea Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 240 South Korea Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 241 Singapore Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 242 Singapore Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 243 Singapore Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 244 Singapore Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 245 Singapore Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 246 Singapore Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 247 Singapore Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 248 Singapore Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 249 Malaysia Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 250 Malaysia Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 251 Malaysia Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 252 Malaysia Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 253 Malaysia Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 254 Malaysia Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 255 Malaysia Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 256 Malaysia Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 257 Rest of Asia Pacific Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 258 Rest of Asia Pacific Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 259 Rest of Asia Pacific Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 260 Rest of Asia Pacific Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 261 Rest of Asia Pacific Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 262 Rest of Asia Pacific Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 263 Rest of Asia Pacific Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 264 Rest of Asia Pacific Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Continued Process Verification Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Continued Process Verification Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Process Qualification Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Process Qualification Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Process Design Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Process Design Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 277 LAMEA In House Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA In House Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Bioprocess Residuals Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Bioprocess Residuals Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Extractables & Leachables Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Extractables & Leachables Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Viral Clearance Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Viral Clearance Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Filtration & Fermentation Systems Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Filtration & Fermentation Systems Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Bioprocess Validation Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Bioprocess Validation Market by Country, 2022 - 2028, USD Million
  • TABLE 295 Brazil Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 296 Brazil Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 297 Brazil Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 298 Brazil Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 299 Brazil Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 300 Brazil Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 301 Brazil Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 302 Brazil Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 303 Argentina Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 304 Argentina Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 305 Argentina Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 306 Argentina Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 307 Argentina Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 308 Argentina Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 309 Argentina Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 310 Argentina Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 311 UAE Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 312 UAE Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 313 UAE Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 314 UAE Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 315 UAE Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 316 UAE Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 317 UAE Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 318 UAE Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 319 Saudi Arabia Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 320 Saudi Arabia Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 321 Saudi Arabia Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 322 Saudi Arabia Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 323 Saudi Arabia Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 324 Saudi Arabia Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 325 Saudi Arabia Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 326 Saudi Arabia Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 327 South Africa Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 328 South Africa Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 329 South Africa Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 330 South Africa Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 331 South Africa Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 332 South Africa Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 333 South Africa Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 334 South Africa Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 335 Nigeria Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 336 Nigeria Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 337 Nigeria Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 338 Nigeria Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 339 Nigeria Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 340 Nigeria Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 341 Nigeria Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 342 Nigeria Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 343 Rest of LAMEA Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 344 Rest of LAMEA Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 345 Rest of LAMEA Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 346 Rest of LAMEA Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 347 Rest of LAMEA Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 348 Rest of LAMEA Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 349 Rest of LAMEA Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 350 Rest of LAMEA Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 351 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 352 Key Information - Eurofins Scientific SE
  • TABLE 353 KEY INFORMATION - Sartorius AG
  • TABLE 354 key Information - Merck KGaA
  • TABLE 355 Key Information - Lonza Group AG
  • TABLE 356 Key Information - Danaher Corporation
  • TABLE 357 key information - Charles River Laboratories International, Inc.
  • TABLE 358 Key Information - SGS S.A.
  • TABLE 359 Key Information - Labcorp corporation
  • TABLE 360 Key Information - Cobetter filtration equipment co., ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Bioprocess Validation Market share by Stage, 2021
  • FIG 3 Global Bioprocess Validation Market share by Stage, 2028
  • FIG 4 Global Bioprocess Validation Market by Stage, 2018 - 2028, USD Million
  • FIG 5 Global Bioprocess Validation Market share by Mode, 2021
  • FIG 6 Global Bioprocess Validation Market share by Mode, 2028
  • FIG 7 Global Bioprocess Validation Market by Mode, 2018 - 2028, USD Million
  • FIG 8 Global Bioprocess Validation Market share by Testing Type, 2021
  • FIG 9 Global Bioprocess Validation Market share by Testing Type, 2028
  • FIG 10 Global Bioprocess Validation Market by Testing Type, 2018 - 2028, USD Million
  • FIG 11 Global Bioprocess Validation Market share by Region, 2021
  • FIG 12 Global Bioprocess Validation Market share by Region, 2028
  • FIG 13 Global Bioprocess Validation Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: thermo fisher scientific, inc.
  • FIG 15 Recent strategies and developments: Sartorius AG
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!